Health & Fitness
Health and Fitness
Health and Fitness 
Thu, May 3, 2012
Wed, May 2, 2012
Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8,
Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual... -- SAN DIEGO, May 2, 2012 /PRNewswire/ --
Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
SAN DIEGO, May 2, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Chief Commercial Officer Scott Byrd will present the company's corporate overview on Tuesday, May 8, 2012 at 4:50pm Eastern Time (1:50pm Pacific Time) during the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference at the Intercontinental Boston Hotel in Boston.
The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of [ www.cadencepharm.com ], under "Events and Presentations."
Contacts: | William R. LaRue |
SVP, CFO | |
Cadence Pharmaceuticals, Inc. | |
858-436-1400 |
SOURCE Cadence Pharmaceuticals, Inc.
[ Back to top ] RELATED LINKS
[ http://www.cadencepharm.com ]